Recombinant multi-species BLTP2/KIAA0100 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BLTP2/KIAA0100 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was initially characterized in human as having high expression levels in breast carcinomas and breast cancer cell lines. This gene also has increased expression in prostrate cancer cells relative to normal prostrate tissues. Expression of this gene is negatively regulated by direct binding of the microRNA miR-195 to its 3' UTR. miR-195 has been shown to modulate the invasiveness of prostrate cancer cells and xenograft metastases by downgrading expression of this gene. In mouse, the protein encoded by this gene was identified as an antigen on acute monocytic leukemia cells. In human, alternative splicing results in multiple transcript variants encoding distinct isoforms; some of these isoforms are predicted to contain an RNA pol II promoter FMP27 protein domain and a Golgi-body-localization APT1 domain. [provided by RefSeq, Apr 2017]
The Alternative Names of target: 2610507B11Rik,Antigen MLAA-22,BCOX,BCOX1,BLTP2,Bltp2,Breast cancer-overexpressed gene 1 protein,Bridge-like lipid transfer protein family member 2,CT101,D11Bhm178e,D11Bhm179e,E1,FMP27,Hob,KIAA0100,Protein hobbit homolog,RGD1307929,mKIAA0100

Target products collectionGo to BLTP2/KIAA0100 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0294-Ag-1/ GM-Tg-hg-SE0294-Ag-2 Human BLTP2/KIAA0100 protein Human
GM-Tg-rg-SE0294-Ag-1/ GM-Tg-rg-SE0294-Ag-2 Rat BLTP2/KIAA0100 protein Rat
GM-Tg-mg-SE0294-Ag-1/ GM-Tg-mg-SE0294-Ag-2 Mouse BLTP2/KIAA0100 protein Mouse
GM-Tg-cynog-SE0294-Ag-1/ GM-Tg-cynog-SE0294-Ag-2 Cynomolgus/Rhesus macaque BLTP2/KIAA0100 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0294-Ag-1/ GM-Tg-felg-SE0294-Ag-2 Feline BLTP2/KIAA0100 protein Feline
GM-Tg-cang-SE0294-Ag-1/ GM-Tg-cang-SE0294-Ag-2 Canine BLTP2/KIAA0100 protein Canine
GM-Tg-bovg-SE0294-Ag-1/ GM-Tg-bovg-SE0294-Ag-2 Bovine BLTP2/KIAA0100 protein Bovine
GM-Tg-equg-SE0294-Ag-1/ GM-Tg-equg-SE0294-Ag-2 Equine BLTP2/KIAA0100 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0294-Ag-1/ GM-Tg-hg-SE0294-Ag-2; GM-Tg-rg-SE0294-Ag-1/ GM-Tg-rg-SE0294-Ag-2;
GM-Tg-mg-SE0294-Ag-1/ GM-Tg-mg-SE0294-Ag-2; GM-Tg-cynog-SE0294-Ag-1/ GM-Tg-cynog-SE0294-Ag-2;
GM-Tg-felg-SE0294-Ag-1/ GM-Tg-felg-SE0294-Ag-2; GM-Tg-cang-SE0294-Ag-1/ GM-Tg-cang-SE0294-Ag-2;
GM-Tg-bovg-SE0294-Ag-1/ GM-Tg-bovg-SE0294-Ag-2; GM-Tg-equg-SE0294-Ag-1/ GM-Tg-equg-SE0294-Ag-2
Products Name BLTP2/KIAA0100 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name BLTP2/KIAA0100
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BLTP2/KIAA0100 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.